Financhill
Back

JPMorgan Nasdaq Equity Premium Income ETF Vs. Revolution Medicines, Inc. Industry Stock Comparison

Sell
43

JEPQ
JPMorgan Nasdaq Equity Premium Income ETF

Last Price:
$59.16
Seasonality Move:
1.86%
Buy
71

RVMD
Revolution Medicines, Inc.

Last Price:
$118.94
Seasonality Move:
-1.63%
Sell
43
JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) is a Sell

Is JPMorgan Nasdaq Equity Premium Income ETF a Buy, Sell or Hold?

  • The current JPMorgan Nasdaq Equity Premium Income ETF [JEPQ] share price is $59.16. The Score for JEPQ is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • JEPQ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Revolution Medicines, Inc. (RVMD) is a Buy

Is Revolution Medicines, Inc. a Buy, Sell or Hold?

  • The current Revolution Medicines, Inc. [RVMD] share price is $118.64. The Score for RVMD is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • RVMD is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

JEPQ Stock Price Chart

What is JPMorgan Nasdaq Equity Premium Income ETF's stock price today?

  • The JPMorgan Nasdaq Equity Premium Income ETF share price today is $59.16
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JEPQ is experiencing buying pressure, which is a positive indicator for future bullish movement.

RVMD Stock Price Chart

What is Revolution Medicines, Inc.'s stock price today?

  • The Revolution Medicines, Inc. share price today is $118.64
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RVMD is experiencing slight buying pressure.

JEPQ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.2 Buy
Relative Strength Index (14 RSI): 56.67 Buy
Chaikin Money Flow: 5174363 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.15 - 59.15) Buy
Bollinger Bands (100): (56.33 - 58.71) Buy

RVMD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 7.63 Buy
Relative Strength Index (14 RSI): 91.23 Buy
Chaikin Money Flow: 10348603 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (72.46 - 92.98) Buy
Bollinger Bands (100): (42.46 - 77.64) Buy

JEPQ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 58.81 Buy
20-day SMA: 58.64 Buy
50-day SMA: 58.37 Buy
200-day SMA: 55.07 Buy
8-day EMA: 58.84 Buy
20-day EMA: 58.66 Buy
50-day EMA: 57.64 Buy
200-day EMA: 38.82 Buy

RVMD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 90.66 Buy
20-day SMA: 83.7 Buy
50-day SMA: 75.06 Buy
200-day SMA: 48.99 Buy
8-day EMA: 96.11 Buy
20-day EMA: 86.55 Buy
50-day EMA: 75.94 Buy
200-day EMA: 55.57 Buy

JPMorgan Nasdaq Equity Premium Income ETF Earnings Growth & JEPQ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Revolution Medicines, Inc. Earnings Growth & RVMD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.74 per share, and an increase next year of $0.61 per share.

JPMorgan Nasdaq Equity Premium Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Revolution Medicines, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):